| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172214 Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury |
| 07/14/2011 | US20110172212 Amine-based compound and use thereof |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171324 Method of treating or preventing disease in bees |
| 07/14/2011 | US20110171319 Nutritional composition made using isolated organic matter |
| 07/14/2011 | US20110171313 Composition containing ultra-micronized palmitoyl-ethanolamide |
| 07/14/2011 | US20110171305 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system |
| 07/14/2011 | US20110171293 Hard capsule composition and method of use |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171274 Fesoterodine Substantially Free of Dehydroxy Impurity |
| 07/14/2011 | US20110171190 Pharmacological vitreolysis |
| 07/14/2011 | US20110171185 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343066A1 Therapeutic agent for hepatitis c |
| 07/13/2011 | EP2342173A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 07/13/2011 | EP2341906A2 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP1984001B1 Fixed-dose association of phytate and zinc |
| 07/13/2011 | EP1733723B1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1259478B1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102119997A Method for establishing HPLC (high performance liquid chromatography) finger-print of ophiopogon japonicus and standard finger-print thereof |
| 07/13/2011 | CN102119983A Traditional Chinese medicine composition for preventing and treating heat stress of livestock and poultry |
| 07/13/2011 | CN101569749B preparation method of dextran-hemoglobin conjugate as potential blood substitute |
| 07/13/2011 | CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977071 Binding moieties based on shark ignar domains |
| 07/12/2011 | US7977059 17867, a novel human aminopeptidase |
| 07/12/2011 | US7976860 A porous protein matrix with a structural component partly or fully anchored in the matrix; at least one surface has a protein membrane crosslinked with the matrix; sufficient stability with improved flexibility, biocompatibility and absorption; vascular prosthetics |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2481268C Medicaments comprising steroids and a novel anticholinergic |
| 07/12/2011 | CA2480266C Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| 07/12/2011 | CA2470078C Selective urokinase inhibitors |
| 07/12/2011 | CA2467676C Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives |
| 07/12/2011 | CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/12/2011 | CA2422617C Tripeptidyl peptidase inhibitors |
| 07/12/2011 | CA2408956C Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 07/12/2011 | CA2376375C Method and composition for inhibiting cardiovascular cell proliferation |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082355A1 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| 07/07/2011 | WO2011081523A1 Interferon analogs |
| 07/07/2011 | WO2011081221A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011081205A1 1,3,4-oxadiazole-2-carboxamide compound |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011081118A1 Pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011081117A1 Solid pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011081083A1 Neuraminic acid derivative, sialidase activity inhibitor and antiinfluenza drug |
| 07/07/2011 | WO2011080984A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011018636A3 Photochemical internalization method |
| 07/07/2011 | WO2011018635A3 Photosensitizing compositions |
| 07/07/2011 | US20110167505 GFATS As Modifiers of the AXIN Pathway and Methods of Use |
| 07/07/2011 | US20110166202 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/07/2011 | US20110166195 Method for the formation of megamitochondria |
| 07/07/2011 | US20110166181 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166111 Composition for the reduction of drip losses in pork |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166077 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 07/07/2011 | US20110165269 Radiation Protection System |
| 07/07/2011 | US20110165268 Liquid Chalcogenide Compositions and Methods of Manufacturing and Using the Same |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation |
| 07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |
| 07/07/2011 | US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 07/07/2011 | US20110165133 Method of de-differentiating and re-differentiating somatic cells using rna |
| 07/07/2011 | US20110165126 Enhanced Submucosal Tissue Graft Constructs |
| 07/07/2011 | US20110165098 Methods to prevent cytotoxicity using n-acetyl-cysteine |
| 07/07/2011 | US20110165095 Composition and method for the inhibition of postoperative adhesions severity |
| 07/07/2011 | US20110165085 Tumor selective fluorescent staining agent |
| 07/07/2011 | US20110165083 Peptides that home to tumor lymphatic vasculature and methods of using same |